Beatriz Estalayo Gutiérrez | Medicine and Dentistry | Best Research Article Award

Mrs. Beatriz Estalayo Gutiérrez | Medicine and Dentistry | Best Research Article Award

Médico de Familia at SERMAS, Spain

Beatriz Estalayo Gutiérrez, a Family Physician with a PhD in Medicine, is a strong candidate for the Best Research Article Award due to her innovative research in mental health, specifically through auditory interventions in primary care. Her work, including the development of the Frequency Modulated Auditory Intervention, addresses anxiety and depression using novel auditory modulation techniques, which have been evaluated in controlled clinical trials and published in reputable journals. Her academic credentials are complemented by significant international experience with Médecins Sans Frontières, where she provided care in conflict zones. While her research has had an important impact, her citation index (H-index of 2) suggests potential for broader influence, and she could benefit from more collaborative research efforts and increased visibility at international conferences. Nevertheless, her contributions to the field of mental health, especially in low-resource settings, make her a deserving candidate for the award.

Professional Profile 

Education🎓

Beatriz Estalayo Gutiérrez holds a PhD in Medicine from the University of Alcalá, completed between 2016 and 2021, where she focused on anxiety and depression in primary care, specifically through auditory interventions. In addition to her doctoral studies, she earned a Master’s Degree in Humanitarian Medicine from CEIC, Complutense University (2006-2007), and a Diploma in Epidemiology and Public Health from Rey Juan Carlos University (2004-2007). She also holds a Bachelor’s Degree in Medicine from UAM, obtained between 1997 and 2003. Her academic training blends medical practice with research, particularly in the fields of mental health and humanitarian medicine. This diverse educational background has equipped her with a deep understanding of both clinical and research aspects of medicine, allowing her to contribute significantly to the study of mental health interventions in primary care settings. Beatriz’s education has laid a strong foundation for her ongoing work in medical research and healthcare.

Professional Experience📝

Beatriz Estalayo Gutiérrez has extensive professional experience as a family physician, with over 16 years of practice in primary care since 2004. She has been a key part of the SERMAS Servicio Madrileño de Salud since 2007, where she has honed her expertise in family medicine, focusing on mental health issues. In addition to her work in Spain, Beatriz has gained significant international experience through her involvement with Médecins Sans Frontières (MSF). She has worked in various crisis regions, including the Turkey-Syria border, the Tunisia-Lebanon border, Port-au-Prince, Haiti, and Madaoua, Niger, providing medical care to displaced populations and those affected by epidemics and natural disasters. This diverse experience has provided her with a global perspective on healthcare delivery in low-resource settings. Beatriz’s combination of clinical experience and humanitarian work has enriched her approach to patient care, particularly in addressing mental health challenges in underserved communities.

Research Interest🔎

Beatriz Estalayo Gutiérrez’s research interests primarily focus on mental health, particularly in primary care settings. Her work explores innovative approaches to treating anxiety and depression, with a specific emphasis on auditory interventions. Beatriz has developed and evaluated the Frequency Modulated Auditory Intervention, which has been tested in controlled clinical trials to assess its effectiveness in modulating auditory perception and improving mental health outcomes. Her research aims to bridge the gap between sensory processing and mental health therapies, highlighting the potential of auditory modulation techniques in treating common mental health conditions. Additionally, Beatriz is interested in the interplay between auditory perception asymmetries and mental health disorders, such as anxiety and depression. Her work contributes to a deeper understanding of how auditory interventions can be used as a therapeutic tool in primary care, offering new insights into improving the mental well-being of patients, especially in underserved populations.

Award and Honor🏆

Beatriz Estalayo Gutiérrez has not yet received major formal awards or honors, but her work has been recognized in the academic and medical communities, particularly for her innovative contributions to mental health research. Her publications, including her research on auditory interventions in the treatment of anxiety and depression, have been published in reputable journals such as the Journal of Clinical Medicine and Symmetry, contributing to her growing recognition in the field of primary care and mental health. Her research has also been cited internationally, indicating a growing influence in the medical and scientific communities. Although she has not yet received a specific award, her continuous academic and professional contributions demonstrate her commitment to advancing healthcare, particularly in the intersection of sensory processing and mental health. Her dedication to improving patient care, especially in underserved settings, highlights her potential for future recognition and awards in the medical research field.

Research Skill🔬

Beatriz Estalayo Gutiérrez possesses strong research skills, particularly in the areas of clinical trials, mental health interventions, and auditory perception. Her ability to design and conduct controlled and randomized clinical trials is evident in her work on the Frequency Modulated Auditory Intervention, which targets anxiety and depression in primary care settings. She demonstrates expertise in data analysis and the development of innovative intervention techniques that bridge sensory processing with mental health treatment. Beatriz’s interdisciplinary knowledge spans from clinical medicine to public health and epidemiology, allowing her to apply diverse methodologies in her research. Her proficiency in publishing findings in peer-reviewed journals further showcases her ability to communicate complex research outcomes effectively to the global scientific community. Additionally, her experience with international humanitarian missions, such as those with Médecins Sans Frontières, adds a unique perspective to her research, particularly in addressing mental health in low-resource and crisis settings.

Conclusion💡

Beatriz Estalayo Gutiérrez is a highly promising candidate for the Best Research Article Award, with her innovative approach to addressing mental health issues through auditory interventions in primary care. Her work has the potential to reshape mental health treatments, particularly in low-resource settings. However, there is room for growth in her citation index and in expanding her collaborative research efforts. Overall, her research has substantial value in both academic and clinical contexts, making her a strong contender for the award.

Publications Top Noted✍️

  • Authors: Beatriz Estalayo-Gutiérrez, María José Álvarez-Pasquín, Francisco Germain

  • Year: 2025

  • Title: Approach to Mental Health Through a Frequency Modulated Auditory Intervention: A Controlled and Randomized Clinical Trial

  • Journal: Journal of Clinical Medicine

  • DOI: 10.3390/jcm14010288

Liying Zhang | Medicine and Dentistry | Best Researcher Award

Dr. Liying Zhang | Medicine and Dentistry | Best Researcher Award

Professor at University of California, Los Angeles, United States

Dr. Liying Zhang, MD, PhD, FACMG, is a distinguished researcher and professor specializing in molecular diagnostics and precision oncology. She serves as the Director of the Advanced Molecular Diagnostics Service at UCLA David Geffen School of Medicine and the Director of Cancer Molecular Diagnostics at UCLA Jonsson Comprehensive Cancer Center. With extensive experience in molecular genetics, her research focuses on cancer diagnostics, biomarker discovery, and precision medicine. She has contributed to numerous high-impact studies, secured significant research funding, and played an active role in national and international expert committees. Her expertise spans clinical molecular genetics, genomics, bioinformatics, and laboratory medicine, making her a leading figure in the field of cancer molecular diagnostics.

Professional Profile 

Education

Dr. Zhang earned her Ph.D. in Biochemistry and Molecular Biology from The Johns Hopkins University in 2003, alongside a Master’s degree in Computer Science with a focus on Bioinformatics in 2002. She obtained her MD from Peking University, Beijing, China, in 1994. She holds multiple clinical licensures and board certifications, including Clinical Molecular Genetics and Genomics from the American Board of Medical Genetics and Genomics. Her strong educational foundation in medicine, biochemistry, molecular biology, and computational science has equipped her with the interdisciplinary expertise required for advancing molecular diagnostics and precision medicine.

Professional Experience

Dr. Zhang has held several prestigious roles in molecular pathology and diagnostics. Since 2020, she has been a Professor and Director at UCLA, leading advanced molecular diagnostics initiatives. Previously, she served as a Director and Molecular Geneticist at Memorial Sloan Kettering Cancer Center from 2005 to 2019, overseeing diagnostic molecular genetics laboratories and contributing to groundbreaking cancer research. Her earlier roles include research positions at the National Research Institute for Family Planning in China. Additionally, she has been actively involved in professional committees, journal reviews, and mentorship programs, furthering advancements in molecular diagnostics and genetic research.

Research Interest

Dr. Liying Zhang’s research focuses on molecular diagnostics, cancer genomics, and precision oncology. She is dedicated to identifying genetic biomarkers that enhance cancer detection, prognosis, and treatment strategies. Her work involves integrating next-generation sequencing (NGS) technologies, bioinformatics, and molecular pathology to improve the accuracy and efficiency of cancer diagnostics. She is particularly interested in the molecular mechanisms underlying tumor development, drug resistance, and targeted therapies. Through collaborations with oncologists, geneticists, and data scientists, she aims to translate genetic findings into clinically actionable insights that improve patient outcomes. Her research also extends to liquid biopsy, epigenetics, and the development of novel molecular assays for early cancer detection.

Awards and Honors

Dr. Zhang has received numerous prestigious awards recognizing her contributions to molecular genetics and cancer diagnostics. She has been honored as a Fellow of the American College of Medical Genetics and Genomics (FACMG), acknowledging her leadership and expertise in clinical molecular genetics. She has also received research excellence awards from institutions such as Memorial Sloan Kettering Cancer Center and UCLA for her groundbreaking work in cancer molecular diagnostics. Additionally, she has been an invited speaker at leading international conferences, including the American Society of Human Genetics (ASHG) and the Association for Molecular Pathology (AMP). Her contributions to scientific research and clinical practice have earned her recognition as a thought leader in precision medicine and molecular oncology.

Research Skills

Dr. Zhang possesses a diverse range of research skills in molecular diagnostics and genomics. She is proficient in next-generation sequencing (NGS) technologies, whole-genome and transcriptome analysis, and single-cell sequencing. She has extensive experience in bioinformatics, data mining, and computational modeling for genetic variant interpretation. Her expertise includes designing and validating molecular assays for clinical diagnostics, including PCR-based and hybrid capture-based sequencing methods. She is also skilled in laboratory management, regulatory compliance, and quality control in clinical molecular genetics laboratories. Additionally, her strong background in translational research allows her to bridge the gap between basic scientific discoveries and clinical applications, ensuring that her findings have a direct impact on patient care and personalized treatment strategies.

Conclusion

Dr. Liying Zhang is highly suitable for the Best Researcher Award due to her exceptional contributions to molecular diagnostics, cancer genomics, and precision medicine. Her extensive experience in research leadership, grant acquisition, and clinical applications makes her an outstanding candidate. Strengthening her independent research leadership and international collaborations would further solidify her candidacy for this prestigious award.

Publications Top Noted

  • Title: Inherited DNA-repair gene mutations in men with metastatic prostate cancer
    Authors: CC Pritchard, J Mateo, MF Walsh, N De Sarkar, W Abida, H Beltran, …
    Year: 2016
    Citation: 1765

  • Title: Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer
    Authors: L Klotz, L Zhang, A Lam, R Nam, A Mamedov, A Loblaw
    Year: 2010
    Citation: 1402

  • Title: Long-term follow-up of a large active surveillance cohort of patients with prostate cancer
    Authors: L Klotz, D Vesprini, P Sethukavalan, V Jethava, L Zhang, S Jain, …
    Year: 2015
    Citation: 1399

  • Title: CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct
    Authors: IYL Tan, AM Demchuk, J Hopyan, L Zhang, D Gladstone, K Wong, …
    Year: 2009
    Citation: 792

  • Title: Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
    Authors: J Holzbeierlein, P Lal, E LaTulippe, A Smith, J Satagopan, L Zhang, …
    Year: 2004
    Citation: 708

  • Title: Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer
    Authors: A Latham, P Srinivasan, Y Kemel, J Shia, C Bandlamudi, D Mandelker, …
    Year: 2019
    Citation: 591

  • Title: Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making
    Authors: W Abida, J Armenia, A Gopalan, R Brennan, M Walsh, D Barron, D Danila, …
    Year: 2017
    Citation: 583

  • Title: Celiac disease: summary
    Authors: A Rostom, C Dubé, A Cranney, N Saloojee, R Sy, C Garritty, M Sampson, …
    Year: 2004
    Citation: 511

  • Title: Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing
    Authors: D Mandelker, L Zhang, Y Kemel, ZK Stadler, V Joseph, A Zehir, …
    Year: 2017
    Citation: 508

  • Title: Tumour lineage shapes BRCA-mediated phenotypes
    Authors: P Jonsson, C Bandlamudi, ML Cheng, P Srinivasan, SS Chavan, …
    Year: 2019
    Citation: 384

  • Title: Hereditary diffuse gastric cancer: updated clinical practice guidelines
    Authors: VR Blair, M McLeod, F Carneiro, DG Coit, JL D’Addario, JM van Dieren, …
    Year: 2020
    Citation: 381

  • Title: Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases
    Authors: E Chow, P Hoskin, G Mitera, L Zeng, S Lutz, D Roos, C Hahn, …
    Year: 2012
    Citation: 374

  • Title: Reliable pan-cancer microsatellite instability assessment by using targeted next-generation sequencing data
    Authors: S Middha, L Zhang, K Nafa, G Jayakumaran, D Wong, HR Kim, …
    Year: 2017
    Citation: 363

  • Title: Genetic predictors of response to systemic therapy in esophagogastric cancer
    Authors: YY Janjigian, F Sanchez-Vega, P Jonsson, WK Chatila, JF Hechtman, …
    Year: 2018
    Citation: 352